Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesVisualizing the von Willebrand factor/glycoprotein Ib-IX axis with a platelet-type von Willebrand disease mutation
Blood, 10/09/09
Guerrero JA et al. – Visualization of the receptor/ligand interaction and characterization of a severe anti–thrombotic phenotype provides a new understanding on the molecular basis of bleeding associated with the PT–VWD phenotype.
Related Articles
Identification and prevalence of von Willebrand disease type 2N (Normandy) in Australia
Blood Coagulation & Fibrinolysis, 11/03/09
Relevance Score: 80%
Oxidative modification of von Willebrand factor by neutrophil oxidants inhibits its cleavage by ADAMTS13
Blood, 10/13/09
Relevance Score: 80%
Hemostasis, Inflammation, and Fatal and Nonfatal Coronary Heart Disease. Long-Term Follow-Up of the Atherosclerosis Risk in Communities (ARIC) Cohort
Arteriosclerosis, Thrombosis, and Vascular Biology, 10/06/09
Relevance Score: 80%
ADAMTS13 and von Willebrand factor concentrations in patients with diabetes mellitus
Blood Coagulation & Fibrinolysis, 11/03/09
Relevance Score: 79%
Shear-induced interaction of platelets with von Willebrand factor results in glycoprotein Ib-alpha shedding
Heart And Circulatory Physiology, 11/02/09
Relevance Score: 79%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Thrombopoietin in normal and neoplastic stem cell development
Best Practice & Research: Clinical Haematology , 12/07/09
Mechanisms of mutations in myeloproliferative neoplasms
Best Practice & Research: Clinical Haematology , 12/07/09
Ursodeoxycholic acid switches oxaliplatin-induced necrosis to apoptosis by inhibiting reactive oxygen species production and activating p53-caspase 8 pathway in HepG2 hepatocellular carcinoma
International Journal of Cancer, 12/07/09
Today in Coagulation/Bleeding Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
Intracranial Hemorrhage in Acute and Chronic Childhood Immune Thrombocytopenic Purpura over a Ten-Year Period: An Egyptian Multicenter Study
Acta Haematologica, 12/07/09
Hematological Issues in Critically Ill Patients with Cancer
Critical Care Clinics, 12/04/09
Pharmacokinetics and safety of fibrinogen concentrate
Journal of Thrombosis and Haemostasis, 12/03/09
Sponsor
Article Search
Sponsor
Sponsor